Qu et al. (2022) also reported tumor heterogeneity, with ASCL1, NEUROD1, POU2F3, and YAP1 being the predominant molecular SCLC subtypes with frequencies of 78.2%, 5.6%, 7%, and 2.8%, respectively. Here, ASCL1 is linked to small cell lung carcinoma.